Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply, Bloomberg News reports

GSK (GSK.L), Sanofi (SASY.PA),  and CSL Ltd (CSL.AX),  have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, Bloomberg News reported on Friday.

The move comes as a multi-state outbreak among livestock and poultry has caused several human infections, raising concerns about further spread.